Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Bone marrow fibrosis in primary myelofibrosis in relation to myelodysplasia- and age-related mutations of hematopoietic cells].

Der Pathologe - 1 Dec 2020

Bartels S, Faisal M, Büsche G, Schlue J, Hasemeier B, Schipper E, Vogtmann J, Westphal L, Lehmann U, Kreipe H

Abstract excerpt

Besides histopathological findings, there are no indicators of increased risk for fibrotic progression in myeloproliferative neoplasms (MPNs). Age-related clonal hematopoiesis (ARCH) or clonal hematopoiesis of indetermined potential (CHIP) are frequent findings in the elderly and combinations with MPN driver mutations (JAK2, MPL, and CALR) have been described. To determine the impact of ARCH/CHIP-related...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Fibrosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematopoietic Stem Cell Transplantation

Share to Janus Kinase 2

Share to Mutation

Share to Primary Myelofibrosis

Source

Identifiers

PMID: 33113046
DOI: 10.1007/s00292-020-00828-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Bone marrow fibrosis in primary myelofibrosis in relation to myelodysplasia- and age-related mutations of hematopoietic cells].PMID 33113046Read ↗

Mutations associated with age-related clonal hematopoiesis in PMF patients with rapid progression to myelofibrosis.Semantic proximity Read ↗

The shadowlands of MDS: idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP).Semantic proximity Read ↗

[The role of driver and subclonal mutations in pathogenesis of primary myelofibrosis].Semantic proximity Read ↗

Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis.Semantic proximity Read ↗

ICUS/CCUS/CHIP: basics & beyond.Semantic proximity Read ↗

Myelofibrosis: challenges for preclinical models and emerging therapeutic targets.Semantic proximity Read ↗

Histological and molecular classification of chronic myeloproliferative disorders in the age of JAK2: persistence of old questions despite new answers.Semantic proximity Read ↗

Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients.Semantic proximity Read ↗

Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies.Semantic proximity Read ↗

Profile of fibrosis-related gene transcripts and megakaryocytic changes in the bone marrow of myelodysplastic syndromes with fibrosis.Semantic proximity Read ↗

Disease characteristics and outcomes in younger adults with primary and secondary myelofibrosis.Semantic proximity Read ↗

Primary myelofibrosis and the "bad seeds in bad soil" conceptSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.